Name of Issuer:
Forte Biosciences, Inc. (the “Issuer”)
Address of Issuer’s Principal Executive
1124 W Carson Street, MRL Building 3-320, Torrance, California 90502
Names of Persons Filing:
The names of the persons filing this report (collectively, the
“Reporting Persons”) are:
Perceptive Advisors LLC (“Perceptive Advisors”)
Joseph Edelman (“Mr. Edelman”)
Perceptive Life Sciences Master Fund, Ltd. (the “Master Fund”)
Address of Principal Business Office or, if
The address of the principal business office of each of the
Reporting Persons is:
51 Astor Place, 10th Floor
New York, NY 10003
Perceptive Advisors is a Delaware limited liability company
Mr. Edelman is a United States citizen
The Master Fund is a Cayman Islands corporation
Title of Class of
Common Stock, $0.001 par value per share (“Common Stock”)
If this statement is filed pursuant to
§§240.13d-1(b) or 240.13d-2(b) or (c), check
whether the person filing is a:
The information required by this item with respect to each
Reporting Person is set forth in Rows 5 through 9 and 11 of the
cover page to this Schedule 13G. The ownership percentages reported
are based on 13,508,862 outstanding shares of Common Stock, as
reported in the Issuer’s Form 10-K filed on March 16, 2021.
The Master Fund directly holds 700,000 shares of Common Stock.
Perceptive Advisors serves as the investment manager to the Master
Fund and may be deemed to beneficially own such shares.
Mr. Edelman is the managing member of Perceptive Advisors and
may be deemed to beneficially own such shares.